Details for: PRNP

Gene ID: 5621

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: PRNP

Ensembl ID: ENSG00000171867

Description: prion protein (Kanno blood group)

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 40.78
    rCSI 27.47%
    PRS 72.27
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 37.45
    rCSI 44.72%
    PRS 78.92
  • sncg GABAergic cortical interneuron CL4023015
    CSI 35.62
    rCSI 57.29%
    PRS 43.48
  • OFF-bipolar cell CL0000750
    CSI 35.38
    rCSI 48.38%
    PRS 66.77
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 35.32
    rCSI 59.29%
    PRS 41.32
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 27.36
    rCSI 59.36%
    PRS 47.53
  • sst GABAergic cortical interneuron CL4023017
    CSI 27.3
    rCSI 35.2%
    PRS 42.54
  • VIP GABAergic cortical interneuron CL4023016
    CSI 25.91
    rCSI 30.94%
    PRS 41.14
  • skin fibroblast CL0002620
    CSI 23.61
    rCSI 20.36%
    PRS 65.13
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 23.38
    rCSI 41.28%
    PRS 40.31
  • group 3 innate lymphoid cell CL0001071
    CSI 21.02
    rCSI 15.8%
    PRS 64.46
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 21.01
    rCSI 50.24%
    PRS 46.85
  • endothelial cell of lymphatic vessel CL0002138
    CSI 20.86
    rCSI 41.34%
    PRS 74.22
  • pulmonary ionocyte CL0017000
    CSI 20.25
    rCSI 24.65%
    PRS 66.85
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 20.01
    rCSI 34.23%
    PRS 77.63
  • retinal cone cell CL0000573
    CSI 19.68
    rCSI 31.67%
    PRS 48.95
  • retinal pigment epithelial cell CL0002586
    CSI 19.67
    rCSI 39.05%
    PRS 57.2
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 18.91
    rCSI 35.75%
    PRS 78.27
  • ON-bipolar cell CL0000749
    CSI 18.02
    rCSI 26.78%
    PRS 60.99
  • tracheobronchial smooth muscle cell CL0019019
    CSI 17.73
    rCSI 31.27%
    PRS 67.72
  • L6b glutamatergic cortical neuron CL4023038
    CSI 17.53
    rCSI 54.78%
    PRS 42.88
  • keratinocyte CL0000312
    CSI 17.27
    rCSI 14.48%
    PRS 63.76
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 16.61
    rCSI 51.95%
    PRS 45.48
  • cerebral cortex neuron CL0010012
    CSI 16.1
    rCSI 65.61%
    PRS 54.11
  • T follicular helper cell CL0002038
    CSI 15.45
    rCSI 11.56%
    PRS 74.31
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 15.38
    rCSI 37.39%
    PRS 39.97
  • conjunctival epithelial cell CL1000432
    CSI 15.06
    rCSI 23.01%
    PRS 59.88
  • naive T cell CL0000898
    CSI 14.77
    rCSI 10.28%
    PRS 74.24
  • plasmacytoid dendritic cell, human CL0001058
    CSI 14.42
    rCSI 10.07%
    PRS 61.99
  • extravillous trophoblast CL0008036
    CSI 13.55
    rCSI 16.77%
    PRS 55.55
  • lung interstitial macrophage CL4033043
    CSI 13.3
    rCSI 29.85%
    PRS 77.52
  • vein endothelial cell CL0002543
    CSI 13.24
    rCSI 36.12%
    PRS 78.07
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 12.17
    rCSI 46.01%
    PRS 42.17
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 11.84
    rCSI 8.5%
    PRS 73.53
  • pulmonary artery endothelial cell CL1001568
    CSI 11.73
    rCSI 15.96%
    PRS 71.05
  • epithelial cell of lower respiratory tract CL0002632
    CSI 11.06
    rCSI 8.57%
    PRS 60.78
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 10.84
    rCSI 39%
    PRS 39.77
  • interneuron CL0000099
    CSI 10.21
    rCSI 20.5%
    PRS 48.49
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 10.17
    rCSI 20.27%
    PRS 77.01
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 9.94
    rCSI 58.53%
    PRS 42.64
  • intestinal tuft cell CL0019032
    CSI 9.91
    rCSI 15.14%
    PRS 63.52
  • enteroglial cell CL4040002
    CSI 9.9
    rCSI 52.04%
    PRS 65.17
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 9.64
    rCSI 31.69%
    PRS 46.48
  • vascular leptomeningeal cell CL4023051
    CSI 9.42
    rCSI 16.52%
    PRS 51.42
  • CD4-positive helper T cell CL0000492
    CSI 9.4
    rCSI 7.11%
    PRS 73.1
  • retinal ganglion cell CL0000740
    CSI 9.27
    rCSI 20.47%
    PRS 45.65
  • neuron CL0000540
    CSI 9.19
    rCSI 24.47%
    PRS 48.85
  • mature T cell CL0002419
    CSI 8.48
    rCSI 6.6%
    PRS 77.26
  • glioblast CL0000030
    CSI 8.38
    rCSI 13.37%
    PRS 52.09
  • mononuclear phagocyte CL0000113
    CSI 8.34
    rCSI 18.35%
    PRS 63.44
  • central nervous system neuron CL2000029
    CSI 7.89
    rCSI 57.99%
    PRS 46.3
  • tuft cell of colon CL0009041
    CSI 7.89
    rCSI 18.38%
    PRS 72.2
  • myofibroblast cell CL0000186
    CSI 7.72
    rCSI 10.69%
    PRS 60.74
  • choroid plexus epithelial cell CL0000706
    CSI 7.65
    rCSI 12.53%
    PRS 48.72
  • inhibitory interneuron CL0000498
    CSI 7.48
    rCSI 17.27%
    PRS 48.67
  • plasmablast CL0000980
    CSI 7.48
    rCSI 5.88%
    PRS 65.89
  • fibroblast of lung CL0002553
    CSI 7.42
    rCSI 6.91%
    PRS 59.67
  • alveolar type 1 fibroblast cell CL4028004
    CSI 7.42
    rCSI 8.12%
    PRS 63.21
  • mature alpha-beta T cell CL0000791
    CSI 7.33
    rCSI 26.52%
    PRS 78.88
  • stromal cell of ovary CL0002132
    CSI 7.32
    rCSI 20.12%
    PRS 72.11
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 7.16
    rCSI 6.62%
    PRS 78.94
  • secretory cell CL0000151
    CSI 7.15
    rCSI 7.46%
    PRS 59.47
  • basal cell CL0000646
    CSI 7.13
    rCSI 9.53%
    PRS 59.64
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 7.06
    rCSI 5.37%
    PRS 72.08
  • ciliated epithelial cell CL0000067
    CSI 6.79
    rCSI 5.97%
    PRS 47.17
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 6.76
    rCSI 8.42%
    PRS 39.38
  • perivascular cell CL4033054
    CSI 6.76
    rCSI 9.24%
    PRS 65.15
  • class switched memory B cell CL0000972
    CSI 6.67
    rCSI 4.98%
    PRS 76.08
  • dendritic cell, human CL0001056
    CSI 6.65
    rCSI 10.21%
    PRS 68.01
  • respiratory basal cell CL0002633
    CSI 6.64
    rCSI 6.88%
    PRS 64.68
  • fallopian tube secretory epithelial cell CL4030006
    CSI 6.59
    rCSI 6.34%
    PRS 59.42
  • retinal bipolar neuron CL0000748
    CSI 6.55
    rCSI 12.27%
    PRS 47.9
  • alpha-beta T cell CL0000789
    CSI 6.54
    rCSI 7.67%
    PRS 75.91
  • regular ventricular cardiac myocyte CL0002131
    CSI 6.31
    rCSI 39.42%
    PRS 51.27
  • blood vessel endothelial cell CL0000071
    CSI 6.31
    rCSI 13.08%
    PRS 56.52
  • myeloid leukocyte CL0000766
    CSI 6.29
    rCSI 5.8%
    PRS 60.62
  • neural progenitor cell CL0011020
    CSI 6.27
    rCSI 27.58%
    PRS 50.07
  • group 2 innate lymphoid cell CL0001069
    CSI 6.19
    rCSI 33.47%
    PRS 87.22
  • bronchus fibroblast of lung CL2000093
    CSI 6.05
    rCSI 4.91%
    PRS 59.85
  • double negative thymocyte CL0002489
    CSI 5.94
    rCSI 4.13%
    PRS 70.1
  • granulocyte CL0000094
    CSI 5.91
    rCSI 9.03%
    PRS 68.57
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 5.91
    rCSI 16.94%
    PRS 78.88
  • cerebellar granule cell CL0001031
    CSI 5.86
    rCSI 8.61%
    PRS 53.26
  • corneal epithelial cell CL0000575
    CSI 5.79
    rCSI 16.58%
    PRS 72.56
  • stem cell CL0000034
    CSI 5.7
    rCSI 5.5%
    PRS 49.8
  • retina horizontal cell CL0000745
    CSI 5.68
    rCSI 8.66%
    PRS 55.58
  • Schwann cell CL0002573
    CSI 5.53
    rCSI 15.72%
    PRS 57.72
  • lung pericyte CL0009089
    CSI 5.49
    rCSI 14.5%
    PRS 68.16
  • pro-B cell CL0000826
    CSI 5.46
    rCSI 4.53%
    PRS 61.14
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 5.42
    rCSI 7.1%
    PRS 72.89
  • Mueller cell CL0000636
    CSI 5.4
    rCSI 12.33%
    PRS 51.24
  • alveolar adventitial fibroblast CL4028006
    CSI 5.38
    rCSI 8.49%
    PRS 61.3
  • intermediate monocyte CL0002393
    CSI 5.31
    rCSI 8.01%
    PRS 63.15
  • innate lymphoid cell CL0001065
    CSI 5.18
    rCSI 10.69%
    PRS 61.5
  • monocyte CL0000576
    CSI 5.17
    rCSI 9.35%
    PRS 74.23
  • basal cell of prostate epithelium CL0002341
    CSI 5.05
    rCSI 14.61%
    PRS 72.26
  • neural crest cell CL0011012
    CSI 5
    rCSI 3.96%
    PRS 46.17
  • neural cell CL0002319
    CSI 4.98
    rCSI 18.8%
    PRS 46.05
  • T-helper 17 cell CL0000899
    CSI 4.94
    rCSI 3.92%
    PRS 80.96
  • ependymal cell CL0000065
    CSI 4.89
    rCSI 9.93%
    PRS 39.05
  • mesenchymal stem cell CL0000134
    CSI 0.2
    rCSI 1.9%
    PRS 72.4%
  • blood vessel smooth muscle cell CL0019018
    CSI 0.3
    rCSI 2.5%
    PRS 52.6%
  • erythroid progenitor cell CL0000038
    CSI 0.3
    rCSI 2.0%
    PRS 68.7%
  • tracheobronchial serous cell CL0019001
    CSI 0.4
    rCSI 1.9%
    PRS 71.9%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.5
    rCSI 2.7%
    PRS 78.5%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.5
    rCSI 7.1%
    PRS 76.6%
  • OFF midget ganglion cell CL4033047
    CSI 0.5
    rCSI 10.0%
    PRS 51.7%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.5
    rCSI 3.8%
    PRS 74.6%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.6
    rCSI 2.8%
    PRS 71.7%
  • cytotoxic T cell CL0000910
    CSI 0.6
    rCSI 3.7%
    PRS 68.9%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.6
    rCSI 4.4%
    PRS 72.7%
  • GABAergic amacrine cell CL4030027
    CSI 0.7
    rCSI 2.4%
    PRS 48.6%
  • pancreatic stellate cell CL0002410
    CSI 0.7
    rCSI 4.1%
    PRS 68.6%
  • Hofbauer cell CL3000001
    CSI 0.7
    rCSI 1.3%
    PRS 69.9%
  • dopaminergic neuron CL0000700
    CSI 0.8
    rCSI 4.5%
    PRS 44.6%
  • epithelial cell of urethra CL1000296
    CSI 0.8
    rCSI 20.3%
    PRS 77.2%
  • cone retinal bipolar cell CL0000752
    CSI 0.9
    rCSI 11.1%
    PRS 72.9%
  • hepatocyte CL0000182
    CSI 0.9
    rCSI 1.6%
    PRS 58.4%
  • invaginating midget bipolar cell CL4033034
    CSI 1.0
    rCSI 5.6%
    PRS 54.5%
  • chondrocyte CL0000138
    CSI 1.0
    rCSI 1.5%
    PRS 51.6%
  • forebrain radial glial cell CL0013000
    CSI 1.0
    rCSI 3.1%
    PRS 64.6%
  • endothelial cell of placenta CL0009092
    CSI 1.0
    rCSI 4.8%
    PRS 70.6%
  • mesenchymal cell CL0008019
    CSI 1.0
    rCSI 2.7%
    PRS 53.6%
  • hair follicular keratinocyte CL2000092
    CSI 1.1
    rCSI 18.2%
    PRS 82.9%
  • ionocyte CL0005006
    CSI 1.1
    rCSI 1.1%
    PRS 58.4%
  • mature B cell CL0000785
    CSI 1.1
    rCSI 1.0%
    PRS 69.9%
  • memory T cell CL0000813
    CSI 1.1
    rCSI 2.1%
    PRS 85.4%
  • CD34-positive, CD56-positive, CD117-positive common innate lymphoid precursor, human CL0001074
    CSI 1.1
    rCSI 13.0%
    PRS 85.6%
  • Bergmann glial cell CL0000644
    CSI 1.1
    rCSI 1.5%
    PRS 53.3%
  • macroglial cell CL0000126
    CSI 1.2
    rCSI 3.0%
    PRS 59.3%
  • pancreatic PP cell CL0002275
    CSI 1.2
    rCSI 4.8%
    PRS 72.5%
  • duct epithelial cell CL0000068
    CSI 1.2
    rCSI 1.8%
    PRS 63.5%
  • erythroid lineage cell CL0000764
    CSI 1.5
    rCSI 9.3%
    PRS 77.1%
  • tissue-resident macrophage CL0000864
    CSI 1.5
    rCSI 6.9%
    PRS 76.3%
  • common lymphoid progenitor CL0000051
    CSI 1.5
    rCSI 2.0%
    PRS 80.4%
  • promyelocyte CL0000836
    CSI 1.5
    rCSI 2.2%
    PRS 68.8%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.6
    rCSI 8.6%
    PRS 71.9%
  • cardiac muscle cell CL0000746
    CSI 1.6
    rCSI 2.3%
    PRS 49.2%
  • natural T-regulatory cell CL0000903
    CSI 1.7
    rCSI 3.1%
    PRS 88.0%
  • T-helper 1 cell CL0000545
    CSI 1.7
    rCSI 3.0%
    PRS 81.4%
  • hematopoietic stem cell CL0000037
    CSI 1.7
    rCSI 1.1%
    PRS 62.6%
  • type B pancreatic cell CL0000169
    CSI 1.7
    rCSI 3.8%
    PRS 57.2%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 1.8
    rCSI 5.1%
    PRS 60.7%
  • promonocyte CL0000559
    CSI 1.8
    rCSI 3.0%
    PRS 68.2%
  • peripheral nervous system neuron CL2000032
    CSI 1.8
    rCSI 2.5%
    PRS 51.2%
  • pancreatic acinar cell CL0002064
    CSI 1.9
    rCSI 2.5%
    PRS 65.6%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.9
    rCSI 2.6%
    PRS 79.0%
  • IgG plasma cell CL0000985
    CSI 1.9
    rCSI 2.3%
    PRS 76.6%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 2.0
    rCSI 47.7%
    PRS 77.9%
  • retinal rod cell CL0000604
    CSI 2.1
    rCSI 3.6%
    PRS 56.4%
  • common myeloid progenitor CL0000049
    CSI 2.1
    rCSI 1.7%
    PRS 60.5%
  • smooth muscle cell CL0000192
    CSI 2.1
    rCSI 5.0%
    PRS 64.8%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 2.2
    rCSI 2.7%
    PRS 68.0%
  • endocrine cell CL0000163
    CSI 2.2
    rCSI 11.5%
    PRS 86.5%
  • mature microglial cell CL0002629
    CSI 2.3
    rCSI 9.4%
    PRS 59.5%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.3
    rCSI 2.0%
    PRS 64.2%
  • interstitial cell of Cajal CL0002088
    CSI 2.3
    rCSI 2.9%
    PRS 65.8%
  • odontoblast CL0000060
    CSI 2.3
    rCSI 53.0%
    PRS 81.6%
  • adventitial cell CL0002503
    CSI 2.5
    rCSI 5.9%
    PRS 68.2%
  • GABAergic neuron CL0000617
    CSI 2.5
    rCSI 8.3%
    PRS 44.9%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.5
    rCSI 2.4%
    PRS 74.9%
  • direct pathway medium spiny neuron CL4023026
    CSI 2.6
    rCSI 61.4%
    PRS 40.5%
  • indirect pathway medium spiny neuron CL4023029
    CSI 2.6
    rCSI 62.4%
    PRS 41.5%
  • brush cell CL0002204
    CSI 2.6
    rCSI 5.2%
    PRS 76.9%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.7
    rCSI 2.1%
    PRS 59.5%
  • helper T cell CL0000912
    CSI 2.7
    rCSI 3.8%
    PRS 65.1%
  • pancreatic A cell CL0000171
    CSI 2.8
    rCSI 2.9%
    PRS 62.8%
  • activated type II NK T cell CL0000931
    CSI 2.8
    rCSI 3.2%
    PRS 75.7%
  • smooth muscle cell of prostate CL1000487
    CSI 2.8
    rCSI 16.5%
    PRS 75.8%
  • mammary gland epithelial cell CL0002327
    CSI 2.8
    rCSI 9.9%
    PRS 71.9%
  • myoepithelial cell CL0000185
    CSI 2.9
    rCSI 7.2%
    PRS 67.6%
  • inflammatory macrophage CL0000863
    CSI 2.9
    rCSI 4.9%
    PRS 82.7%
  • lung ciliated cell CL1000271
    CSI 2.9
    rCSI 3.3%
    PRS 49.4%
  • mesodermal cell CL0000222
    CSI 2.9
    rCSI 3.5%
    PRS 57.3%
  • astrocyte of the cerebral cortex CL0002605
    CSI 2.9
    rCSI 6.6%
    PRS 42.1%
  • lung neuroendocrine cell CL1000223
    CSI 3.0
    rCSI 4.4%
    PRS 64.6%
  • alternatively activated macrophage CL0000890
    CSI 3.0
    rCSI 3.7%
    PRS 71.4%
  • respiratory suprabasal cell CL4033048
    CSI 3.0
    rCSI 3.8%
    PRS 63.9%
  • lung macrophage CL1001603
    CSI 3.0
    rCSI 6.7%
    PRS 67.0%
  • club cell CL0000158
    CSI 3.0
    rCSI 4.5%
    PRS 55.5%
  • immature B cell CL0000816
    CSI 3.1
    rCSI 2.3%
    PRS 72.5%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 3.1
    rCSI 2.8%
    PRS 56.0%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 3.2
    rCSI 4.3%
    PRS 83.9%
  • enteroendocrine cell CL0000164
    CSI 3.2
    rCSI 4.4%
    PRS 61.1%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 3.2
    rCSI 5.1%
    PRS 83.5%
  • mature astrocyte CL0002627
    CSI 3.3
    rCSI 13.9%
    PRS 53.6%
  • pancreatic ductal cell CL0002079
    CSI 3.3
    rCSI 6.4%
    PRS 62.1%
  • macrophage CL0000235
    CSI 3.4
    rCSI 6.1%
    PRS 78.2%
  • mast cell CL0000097
    CSI 3.4
    rCSI 7.2%
    PRS 78.8%
  • respiratory hillock cell CL4030023
    CSI 3.4
    rCSI 6.0%
    PRS 72.8%
  • cardiac neuron CL0010022
    CSI 3.4
    rCSI 10.8%
    PRS 57.0%
  • glial cell CL0000125
    CSI 3.4
    rCSI 12.9%
    PRS 50.4%
  • pancreatic D cell CL0000173
    CSI 3.4
    rCSI 3.4%
    PRS 61.9%
  • erythrocyte CL0000232
    CSI 3.5
    rCSI 8.0%
    PRS 63.4%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 3.6
    rCSI 2.1%
    PRS 76.5%
  • epithelial cell of lung CL0000082
    CSI 3.7
    rCSI 3.0%
    PRS 58.2%
  • fibroblast of breast CL4006000
    CSI 3.7
    rCSI 15.5%
    PRS 73.4%
  • hepatic stellate cell CL0000632
    CSI 3.7
    rCSI 13.8%
    PRS 51.5%
  • early lymphoid progenitor CL0000936
    CSI 3.8
    rCSI 3.3%
    PRS 64.6%
  • amacrine cell CL0000561
    CSI 3.9
    rCSI 11.2%
    PRS 49.2%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [PRNP](/details-gene/5621) encodes the major prion protein, a glycosylphosphatidylinositol (GPI)-anchored cell surface protein most famously implicated in the pathogenesis of fatal neurodegenerative transmissible spongiform encephalopathies (TSEs), or prion diseases. These include Creutzfeldt-Jakob disease ([176640](https://omim.org/entry/176640)), Gerstmann-Sträussler-Scheinker disease ([137440](https://omim.org/entry/137440)), and fatal familial insomnia ([600072](https://omim.org/entry/600072)). While its misfolded, pathogenic isoform is the causative agent of these conditions, the native protein is expressed in a wide range of tissues and appears to play diverse physiological roles. Expression data indicates significant roles for [PRNP](/details-gene/5621) in both the central nervous system, particularly in various cortical neuron subtypes, and the adaptive immune system, with notably high significance in memory and cytotoxic T lymphocytes. Its molecular functions are broad, encompassing copper ion homeostasis, signal transduction, neuroprotection, and regulation of synaptic processes. ## Cellular Roles and Expression Landscape The expression profile of [PRNP](/details-gene/5621) highlights its importance in two distinct biological systems: the immune system and the central nervous system. **Overall**, the gene shows the highest significance in specific subsets of the adaptive immune system. It is a particularly strong marker for [central memory CD8-positive, alpha-beta T cell](/details-cell/CL0000907)s and [CD8-positive, alpha-beta cytotoxic T cell](/details-cell/CL0000794)s. Its presence in [group 3 innate lymphoid cell](/details-cell/CL0001071)s and [activated CD8-positive, alpha-beta T cell, human](/details-cell/CL0001049)s further underscores a consistent role within the lymphocytic lineage, potentially modulating cell activation and long-term memory. Concurrently, [PRNP](/details-gene/5621) is highly significant across a range of neuronal cell types, consistent with its well-established role in neurobiology. It is prominently expressed in multiple cortical interneuron populations, including [sncg GABAergic cortical interneuron](/details-cell/CL4023015)s, [lamp5 GABAergic cortical interneuron](/details-cell/CL4023011)s, and [sst GABAergic cortical interneuron](/details-cell/CL4023017)s. Its expression is also notable in excitatory neurons, such as [L2/3 intratelencephalic projecting glutamatergic neuron](/details-cell/CL4030059)s. This broad neuronal expression pattern suggests a fundamental role in maintaining neuronal health and function. Beyond these primary domains, [PRNP](/details-gene/5621) shows moderate significance in other cell types, including [skin fibroblast](/details-cell/CL0002620)s and [endothelial cell of lymphatic vessel](/details-cell/CL0002138)s, indicating a broader, though less pronounced, role in stromal and vascular tissues. ## Pathways and Molecular Function Functional annotation reveals the diverse activities of the [PRNP](/details-gene/5621) protein, extending far beyond its role in prion pathology. Its involvement in nervous system development and function is strongly supported by its association with Reactome pathways like `[Axon guidance](/details-gene/R-HSA-422475)` and `[Nervous system development](/details-gene/R-HSA-9675108)`. This is consistent with GO annotations related to synaptic plasticity and maintenance, such as `[dendritic spine maintenance](/details-cell/GO:0097062)` and `[negative regulation of long-term synaptic potentiation](/details-cell/GO:1900272)`. In line with its high expression in T cells, [PRNP](/details-gene/5621) is implicated in the negative regulation of immune responses. GO terms such as `[negative regulation of activated t cell proliferation](/details-cell/GO:0046007)`, `[negative regulation of t cell receptor signaling pathway](/details-cell/GO:0050860)`, and negative regulation of interleukin production (`[GO:0032700](/details-cell/GO:0032700)`, `[GO:0032703](/details-cell/GO:0032703)`) suggest it may function as a molecular brake to control T cell-mediated immunity. At the molecular level, [PRNP](/details-gene/5621) exhibits multiple binding activities. Its well-documented ability to bind metal ions is reflected in the `[copper ion binding](/details-cell/GO:0005507)` annotation. Furthermore, its capacity for `[amyloid-beta binding](/details-cell/GO:0001540)` suggests a potential role in the pathology of Alzheimer's disease, linking it to a broader class of protein misfolding disorders. The protein's function as a scaffold or adaptor is indicated by its involvement in `[protein homooligomerization](/details-cell/GO:0051260)` and its `[molecular adaptor activity](/details-cell/GO:0060090)`, enabling it to participate in diverse signaling complexes at the cell surface. ## Research Directions The dual prominence of [PRNP](/details-gene/5621) in both the immune and nervous systems, coupled with its extensive functional annotations, opens several avenues for future investigation. Understanding how a single protein executes distinct functions in such different cellular contexts is a key challenge. **Proposed Hypotheses:** 1. Given its high expression in memory and cytotoxic T cells and its annotated role in negative regulation of T cell signaling, **`[PRNP](/details-gene/5621)` functions as an inhibitory co-receptor on CD8+ T cells, modulating TCR signaling strength to prevent excessive activation and maintain immune homeostasis.** Loss of [PRNP](/details-gene/5621) on T cells may lead to a lower threshold for activation and a heightened inflammatory response. 2. The pathogenic conversion of the prion protein in neurons disrupts not only cell-autonomous functions but also critical neuro-immune crosstalk. **The native form of `[PRNP](/details-gene/5621)` expressed on neurons is essential for maintaining synaptic integrity by mediating signals from CNS-resident immune cells; this protective interaction is lost upon pathogenic misfolding, accelerating neurodegeneration.** **Experimental Approach:** To test the first hypothesis regarding [PRNP](/details-gene/5621)'s role in T cell regulation, a definitive experiment would involve the specific deletion of [PRNP](/details-gene/5621) in human primary CD8+ T cells using CRISPR-Cas9. These `[PRNP](/details-gene/5621)`-knockout T cells, alongside unmodified controls, could be stimulated *in vitro* via their T cell receptor (TCR). Key readouts would include: (i) proliferation rates, assessed by cell trace violet dilution via flow cytometry; (ii) effector cytokine production (e.g., IFN-gamma, TNF-alpha), measured by ELISA and intracellular staining; and (iii) activation of proximal TCR signaling components (e.g., phosphorylation of LCK, ZAP70, and SLP-76), analyzed by Phosflow or Western blot. An observed hyper-responsive phenotype in knockout cells would support the hypothesis that [PRNP](/details-gene/5621) is a negative regulator of T cell function. **Therapeutic Potential:** As the central pathogenic agent in TSEs, [PRNP](/details-gene/5621) is a primary therapeutic target. The therapeutic strategy is focused on **inhibition** of its pathogenic conversion or **depletion** of the protein altogether. Several approaches are being explored, including antisense oligonucleotides (ASOs) designed to reduce `[PRNP](/details-gene/5621)` mRNA levels, which has shown promise in animal models. Other strategies include small molecules that stabilize the native protein's conformation or monoclonal antibodies that bind the cellular prion protein and prevent its recruitment into pathogenic aggregates. Given the protein's physiological roles, a reduction rather than complete ablation may represent a safer long-term therapeutic strategy.

Genular Protein ID: 705335050

Symbol: APRIO_HUMAN

Name: Alternative prion protein

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11780052

Title: The DNA sequence and comparative analysis of human chromosome 20.

PubMed ID: 11780052

DOI: 10.1038/414865a

PubMed ID: 21478263

Title: An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein.

PubMed ID: 21478263

DOI: 10.1096/fj.10-173815

Sequence Information:

  • Length: 73
  • Mass: 8691
  • Checksum: 4360C28341A4CA52
  • Sequence:
  • MEHWGQPIPG AGQPWRQPLP TSGRWWLGAA SWWWLGAASW WWLGAAPWWW LGTASWWWLG 
    SRRWHPQSVE QAE

Genular Protein ID: 44896081

Symbol: PRIO_HUMAN

Name: Major prion protein

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 3755672

Title: Molecular cloning of a human prion protein cDNA.

PubMed ID: 3755672

DOI: 10.1089/dna.1986.5.315

PubMed ID: 1678248

Title: Genomic structure of the human prion protein gene.

PubMed ID: 1678248

PubMed ID: 9799790

Title: Complete genomic sequence and analysis of the prion protein gene region from three mammalian species.

PubMed ID: 9799790

DOI: 10.1101/gr.8.10.1022

PubMed ID: 10581485

Title: Novel PRNP sequence variant associated with familial encephalopathy.

PubMed ID: 10581485

DOI: 10.1002/(sici)1096-8628(19991215)88:6<653::aid-ajmg14>3.0.co;2-e

PubMed ID: 11780052

Title: The DNA sequence and comparative analysis of human chromosome 20.

PubMed ID: 11780052

DOI: 10.1038/414865a

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 3014653

Title: Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications.

PubMed ID: 3014653

DOI: 10.1126/science.3014653

PubMed ID: 1363802

Title: Deletion in the prion protein gene in a demented patient.

PubMed ID: 1363802

DOI: 10.1093/hmg/1.6.443

PubMed ID: 9384372

Title: A prion-linked psychiatric disorder.

PubMed ID: 9384372

DOI: 10.1038/36757

PubMed ID: 7485229

Title: SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical Alzheimer's disease family.

PubMed ID: 7485229

DOI: 10.1002/ajmg.1320600104

PubMed ID: 1672107

Title: Amyloid protein of Gerstmann-Straussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.

PubMed ID: 1672107

DOI: 10.1002/j.1460-2075.1991.tb07977.x

PubMed ID: 1683708

Title: Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene.

PubMed ID: 1683708

DOI: 10.1073/pnas.88.23.10926

PubMed ID: 9792871

Title: A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.

PubMed ID: 9792871

DOI: 10.1086/302093

PubMed ID: 12732622

Title: Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate.

PubMed ID: 12732622

DOI: 10.1074/jbc.m300394200

PubMed ID: 12214108

Title: The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein.

PubMed ID: 12214108

DOI: 10.3233/jad-2000-2104

PubMed ID: 16144413

Title: The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4.

PubMed ID: 16144413

DOI: 10.1021/ja053254z

PubMed ID: 18034490

Title: The prion protein is a combined zinc and copper binding protein: Zn2+ alters the distribution of Cu2+ coordination modes.

PubMed ID: 18034490

DOI: 10.1021/ja077146j

PubMed ID: 19059915

Title: Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation.

PubMed ID: 19059915

DOI: 10.1074/jbc.m804051200

PubMed ID: 29222195

Title: Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation.

PubMed ID: 29222195

DOI: 10.1074/jbc.w117.000658

PubMed ID: 19349973

Title: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.

PubMed ID: 19349973

DOI: 10.1038/nbt.1532

PubMed ID: 19936054

Title: Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.

PubMed ID: 19936054

DOI: 10.1371/journal.ppat.1000666

PubMed ID: 19381258

Title: Early onset prion disease from octarepeat expansion correlates with copper or zinc binding properties.

PubMed ID: 19381258

DOI: 10.1371/journal.ppat.1000390

PubMed ID: 20375014

Title: Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3.

PubMed ID: 20375014

DOI: 10.1074/jbc.m110.111815

PubMed ID: 20564047

Title: Copper (II) promotes the formation of soluble neurotoxic PrP oligomers in acidic environment.

PubMed ID: 20564047

DOI: 10.1002/jcb.22743

PubMed ID: 21478263

Title: An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein.

PubMed ID: 21478263

DOI: 10.1096/fj.10-173815

PubMed ID: 21153684

Title: Characterizing the novel protein p33MONOX.

PubMed ID: 21153684

DOI: 10.1007/s11010-010-0690-4

PubMed ID: 10954699

Title: Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases.

PubMed ID: 10954699

DOI: 10.1074/jbc.c000483200

PubMed ID: 10618385

Title: NMR solution structure of the human prion protein.

PubMed ID: 10618385

DOI: 10.1073/pnas.97.1.145

PubMed ID: 10900000

Title: NMR structures of three single-residue variants of the human prion protein.

PubMed ID: 10900000

DOI: 10.1073/pnas.97.15.8340

PubMed ID: 11524679

Title: Crystal structure of the human prion protein reveals a mechanism for oligomerization.

PubMed ID: 11524679

DOI: 10.1038/nsb0901-770

PubMed ID: 11900542

Title: Molecular features of the copper binding sites in the octarepeat domain of the prion protein.

PubMed ID: 11900542

DOI: 10.1021/bi011922x

PubMed ID: 14623188

Title: The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site.

PubMed ID: 14623188

DOI: 10.1016/j.jmb.2003.09.048

PubMed ID: 8364585

Title: Mutations and polymorphisms in the prion protein gene.

PubMed ID: 8364585

DOI: 10.1002/humu.1380020303

PubMed ID: 8105771

Title: Genetic and infectious prion diseases.

PubMed ID: 8105771

DOI: 10.1001/archneur.1993.00540110011002

PubMed ID: 17468747

Title: Atomic structures of amyloid cross-beta spines reveal varied steric zippers.

PubMed ID: 17468747

DOI: 10.1038/nature05695

PubMed ID: 19204296

Title: Crystal structure of human prion protein bound to a therapeutic antibody.

PubMed ID: 19204296

DOI: 10.1073/pnas.0809170106

PubMed ID: 19927125

Title: Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.

PubMed ID: 19927125

DOI: 10.1038/emboj.2009.333

PubMed ID: 2564168

Title: Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome.

PubMed ID: 2564168

DOI: 10.1038/338342a0

PubMed ID: 2783132

Title: Pro-->Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome.

PubMed ID: 2783132

DOI: 10.1016/0006-291x(89)92317-6

PubMed ID: 1347910

Title: Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

PubMed ID: 1347910

DOI: 10.1212/wnl.42.3.669

PubMed ID: 1671440

Title: New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred.

PubMed ID: 1671440

DOI: 10.1016/0140-6736(91)91198-4

PubMed ID: 1975028

Title: Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia.

PubMed ID: 1975028

DOI: 10.1016/0140-6736(90)92073-q

PubMed ID: 1363810

Title: Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles.

PubMed ID: 1363810

DOI: 10.1038/ng0492-68

PubMed ID: 1439789

Title: Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.

PubMed ID: 1439789

DOI: 10.1126/science.1439789

PubMed ID: 8461023

Title: Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome.

PubMed ID: 8461023

DOI: 10.1006/bbrc.1993.1275

PubMed ID: 7902693

Title: A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease.

PubMed ID: 7902693

DOI: 10.1002/ana.410340608

PubMed ID: 7902972

Title: A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Straussler-Scheinker disease.

PubMed ID: 7902972

DOI: 10.1212/wnl.43.12.2723-a

PubMed ID: 7699395

Title: A variant of Gerstmann-Straussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene: a clinicopathological study.

PubMed ID: 7699395

DOI: 10.1016/0022-510x(94)90138-4

PubMed ID: 7906019

Title: Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene.

PubMed ID: 7906019

DOI: 10.1212/wnl.44.2.299

PubMed ID: 7913755

Title: Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.

PubMed ID: 7913755

DOI: 10.1098/rstb.1994.0033

PubMed ID: 7783876

Title: Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients.

PubMed ID: 7783876

DOI: 10.1212/wnl.45.6.1127

PubMed ID: 8797472

Title: Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation).

PubMed ID: 8797472

DOI: 10.1212/wnl.47.3.734

PubMed ID: 8909447

Title: Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease.

PubMed ID: 8909447

DOI: 10.1212/wnl.47.5.1305

PubMed ID: 9266722

Title: Familial spongiform encephalopathy associated with a novel prion protein gene mutation.

PubMed ID: 9266722

DOI: 10.1002/ana.410420203

PubMed ID: 9786248

Title: Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity.

PubMed ID: 9786248

DOI: 10.1097/00005072-199810000-00010

PubMed ID: 9482303

Title: Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease.

PubMed ID: 9482303

DOI: 10.1016/s0140-6736(05)78358-6

PubMed ID: 10987652

Title: Molecular genetics of human prion diseases in Germany.

PubMed ID: 10987652

DOI: 10.1007/s004399900124

PubMed ID: 10631141

Title: High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

PubMed ID: 10631141

DOI: 10.1086/302702

PubMed ID: 10790216

Title: Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.

PubMed ID: 10790216

DOI: 10.1002/(sici)1098-1004(200005)15:5<482::aid-humu16>3.0.co;2-1

PubMed ID: 11709001

Title: A new PRNP mutation (G131V) associated with Gerstmann-Straussler-Scheinker disease.

PubMed ID: 11709001

DOI: 10.1001/archneur.58.11.1899

PubMed ID: 12690204

Title: Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.

PubMed ID: 12690204

DOI: 10.1126/science.1083320

PubMed ID: 19923577

Title: A novel protective prion protein variant that colocalizes with kuru exposure.

PubMed ID: 19923577

DOI: 10.1056/nejmoa0809716

PubMed ID: 26061765

Title: A naturally occurring variant of the human prion protein completely prevents prion disease.

PubMed ID: 26061765

DOI: 10.1038/nature14510

Sequence Information:

  • Length: 253
  • Mass: 27661
  • Checksum: 43DB596BAAA66484
  • Sequence:
  • MANLGCWMLV LFVATWSDLG LCKKRPKPGG WNTGGSRYPG QGSPGGNRYP PQGGGGWGQP 
    HGGGWGQPHG GGWGQPHGGG WGQPHGGGWG QGGGTHSQWN KPSKPKTNMK HMAGAAAAGA 
    VVGGLGGYML GSAMSRPIIH FGSDYEDRYY RENMHRYPNQ VYYRPMDEYS NQNNFVHDCV 
    NITIKQHTVT TTTKGENFTE TDVKMMERVV EQMCITQYER ESQAYYQRGS SMVLFSSPPV 
    ILLISFLIFL IVG